Eterna Therapeutics
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 8
- Market Cap
- $9.6M
- Introduction
Eterna Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.
Novel Neural Biomarker ERNA Shows Promise for Optimizing Parkinson's Disease Deep Brain Stimulation
Researchers have identified evoked resonant neural activity (ERNA) as a reliable biomarker that could improve deep brain stimulation electrode placement and programming for Parkinson's disease patients.
© Copyright 2025. All Rights Reserved by MedPath